Literature DB >> 11869321

Comparative study of self-expandable metallic stent and bypass surgery for inoperable esophageal cancer.

T Aoki1, Y Osaka, Y Takagi, R Okada, M Shinohara, A Tsuchida, S Sato, Y Koyanagi.   

Abstract

We evaluated the effect of two different therapies for 23 patients with inoperable esophageal cancer, of whom 13 patients underwent placement of a metallic stent and 10 received bypass surgery. We newly defined the improved level of food intake and the effective rate based on the grade of the patient's status in order to evaluate objectively. Although the effect of stent placement was significantly better than that of bypass surgery, there were no significant differences in the improved level of food intake and the effective rate between the two groups. Four out of 10 patients in the bypass group had suture insufficiency, resulting in no oral intake and a fatal outcome. In addition, the ratio of survival period of ability to ingest orally and in-hospital mortality was significantly favorable in the stent group compared with the bypass group. In conclusion, stent placement should be the first choice for inoperable malignant stenosis or esophageal fistula.

Entities:  

Mesh:

Year:  2001        PMID: 11869321     DOI: 10.1046/j.1442-2050.2001.00186.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  10 in total

1.  Palliative interventions for patients with incurable locally advanced or metastatic thoracic esophageal carcinoma.

Authors:  Tomoyuki Kakuta; Shin-Ichi Kosugi; Hiroshi Ichikawa; Takaaki Hanyu; Takashi Ishikawa; Tatsuo Kanda; Toshifumi Wakai
Journal:  Esophagus       Date:  2019-04-04       Impact factor: 4.230

2.  Bypass Operation for Unresectable Esophageal Cancer: Postoperative Complications After Thoracotomy Versus No Thoracotomy.

Authors:  Masahiro Kimura
Journal:  Indian J Surg       Date:  2016-04-05       Impact factor: 0.656

3.  An Auxetic structure configured as oesophageal stent with potential to be used for palliative treatment of oesophageal cancer; development and in vitro mechanical analysis.

Authors:  Murtaza N Ali; Ihtesham Ur Rehman
Journal:  J Mater Sci Mater Med       Date:  2011-09-06       Impact factor: 3.896

Review 4.  Nonsurgical approaches to esophageal malignancy.

Authors:  Darius Sorbi; David E Fleischer
Journal:  Curr Gastroenterol Rep       Date:  2003-06

5.  Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case.

Authors:  Yoshiro Aoki; Jun Hihara; Kenji Sakogawa; Junya Taomoto; Yoichi Hamai; Manabu Emi; Morihito Okada
Journal:  Surg Today       Date:  2012-09-07       Impact factor: 2.549

Review 6.  Interventions for dysphagia in oesophageal cancer.

Authors:  Yingxue Dai; Chaoying Li; Yao Xie; Xudong Liu; Jianxin Zhang; Jing Zhou; Xiongfei Pan; Shujuan Yang
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

Review 7.  Self-Expandable Metallic Stent Placement for the Palliation of Esophageal Cancer.

Authors:  Kun Yung Kim; Jiaywei Tsauo; Ho Young Song; Pyeong Hwa Kim; Jung Hoon Park
Journal:  J Korean Med Sci       Date:  2017-07       Impact factor: 2.153

8.  Advanced esophageal cancer with tracheobronchial fistula successfully treated by esophageal bypass surgery.

Authors:  Masahiro Kimura; Hideyuki Ishiguro; Tatsuya Tanaka; Hiromitsu Takeyama
Journal:  Int J Surg Case Rep       Date:  2015-03-04

9.  Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma.

Authors:  Dong Tian; Hongying Wen; Maoyong Fu
Journal:  World J Surg Oncol       Date:  2016-01-22       Impact factor: 2.754

10.  Combined brachytherapy and external beam radiation: an effective approach for palliation in esophageal cancer.

Authors:  Sarbani Ghosh Laskar; Shirley Lewis; Jai Prakash Agarwal; Shagun Mishra; Shaesta Mehta; Prachi Patil
Journal:  J Contemp Brachytherapy       Date:  2015-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.